Hovde Group Begins Coverage on GE HealthCare Technologies (NASDAQ:GEHC)

Hovde Group started coverage on shares of GE HealthCare Technologies (NASDAQ:GEHC) in a research note issued to investors on Friday,Benzinga reports. The brokerage set a “market perform” rating and a $14.00 price target on the stock. Hovde Group’s target price would indicate a potential downside of 77.87% from the company’s previous close.

Several other equities analysts have also issued reports on the company. Rothschild & Co Redburn cut their target price on GE HealthCare Technologies from $110.00 to $98.00 in a research note on Thursday, April 30th. Weiss Ratings downgraded shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 15th. Oppenheimer reissued an “outperform” rating and set a $85.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Wells Fargo & Company cut their price target on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a report on Thursday, April 30th. Finally, Jefferies Financial Group reduced their price target on GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. Ten equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $76.41.

GE HealthCare Technologies Stock Down 3.7%

NASDAQ:GEHC traded down $2.45 during trading hours on Friday, reaching $63.25. The company’s stock had a trading volume of 3,728,320 shares, compared to its average volume of 4,429,579. The stock has a 50 day moving average price of $63.65 and a two-hundred day moving average price of $72.03. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The company has a market capitalization of $28.77 billion, a P/E ratio of 15.14, a price-to-earnings-growth ratio of 1.72 and a beta of 0.72. GE HealthCare Technologies has a 12 month low of $58.75 and a 12 month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company’s revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities analysts predict that GE HealthCare Technologies will post 4.89 EPS for the current fiscal year.

Insider Buying and Selling at GE HealthCare Technologies

In related news, Director Rodney F. Hochman acquired 1,618 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were purchased at an average cost of $62.03 per share, with a total value of $100,364.54. Following the completion of the acquisition, the director directly owned 1,618 shares of the company’s stock, valued at $100,364.54. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Peter J. Arduini bought 4,169 shares of the business’s stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average cost of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the transaction, the chief executive officer owned 259,424 shares in the company, valued at $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 21,847 shares of company stock worth $1,361,355 in the last three months. 0.36% of the stock is owned by company insiders.

Institutional Trading of GE HealthCare Technologies

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Banque Cantonale Vaudoise boosted its holdings in GE HealthCare Technologies by 16,539.1% in the first quarter. Banque Cantonale Vaudoise now owns 25,957 shares of the company’s stock valued at $1,849,000 after purchasing an additional 25,801 shares during the last quarter. Allstate Corp raised its stake in shares of GE HealthCare Technologies by 100.3% during the 4th quarter. Allstate Corp now owns 32,688 shares of the company’s stock valued at $2,681,000 after buying an additional 16,365 shares during the last quarter. Salem Investment Counselors Inc. lifted its holdings in shares of GE HealthCare Technologies by 9.2% in the 4th quarter. Salem Investment Counselors Inc. now owns 176,452 shares of the company’s stock valued at $14,473,000 after buying an additional 14,867 shares during the period. Nordea Investment Management AB lifted its holdings in shares of GE HealthCare Technologies by 564.4% in the 4th quarter. Nordea Investment Management AB now owns 284,344 shares of the company’s stock valued at $23,515,000 after buying an additional 241,548 shares during the period. Finally, Northside Capital Management LLC boosted its stake in shares of GE HealthCare Technologies by 16.4% in the fourth quarter. Northside Capital Management LLC now owns 163,614 shares of the company’s stock worth $13,420,000 after buying an additional 23,107 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.